Missouri legislation · 2026 Regular Session
Missouri HB1717: Modifies provisions relating to alternative therapies and treatments, including psilocybin
Status: In committee, May 7, 2026
What the bill says
From the amended text:
SECOND REGULAR SESSION SENATE COMMITTEE SUBSTITUTE FOR HOUSE COMMITTEE SUBSTITUTE FOR HOUSE BILLS NOS. 1717 & 1643 103RD GENERA L ASSEMBLY 4914S.04C KRISTINA MARTIN, Secretary To repeal section 191.480, RSMo, and to enact in lieu thereof three new sections relating to alternative therapies. Section A. Section 191.480, RSMo, is repealed and three new sections enacted in lieu thereof, to be known as sections 191.479, 191.480, and 630.1170, to read as follows: 191.479. 1. As used in this section, the following terms mean: (1) "Bona fide physician-patient relationship", a relationship between a physician and a patient in which the physician: (a) Has completed an assessment of the patient's medical history and current medical condition, including an in-person examination of the patient; (b) Has consulted with the patient with respect to the patient's medical condition; and (c) Is available to provide follow-up care and treatment to the patient; (2) "Facilitator", an individual who is present with a person who uses psilocybin in order to facilitate the therapeutic use of the psilocybin for the person; EXPLANATION-Matter enclosed in bold-faced brackets [thus] in this bill is not enacted and is intended to be omitted in the law. SCS HCS HBs 1717 & 1643 (3) "First responder", any police officer; firefighter; dispatcher for police, fire, or emergency medical services purposes; emergency medical technician or responder; …
Sponsors
- Richard West (R, 102) · primary sponsor
- Stephen Butz (D, 081)
- Matthew Overcast (R, 155)
- Brian Seitz (R, 156)
- William Irwin (R, 055)
Latest actions
- : Placed on Informal Calendar
- : Reported Do Pass (S)
- : Voted Do Pass (S)
- : Executive Session Held (S)
- : Executive Session Scheduled - Wednesday, May 6, 2026
- : Referred: Fiscal Oversight(S)
- : SCS Reported Do Pass (S)
- : SCS Voted Do Pass (S)
- : Executive Session Held (S)
- : Public Hearing Held (S)
Votes
- Third Read and Passed (H) (April 2, 2026): 137 yea, 11 nay, passed
- Reported Do Pass (H) (March 31, 2026): 4 yea, 3 nay, passed
- Reported Do Pass (H) (March 9, 2026): 8 yea, 0 nay, passed
- HCS Reported Do Pass (H) (February 26, 2026): 7 yea, 2 nay, passed
Common questions
- What is HB1717?
- HB1717 is a bill in the Missouri Legislature (2026 Regular Session): Modifies provisions relating to alternative therapies and treatments, including psilocybin.
- What is the status of HB1717?
- In committee as of May 7, 2026. Latest action: Placed on Informal Calendar (May 7, 2026).
- Who sponsored HB1717?
- Richard West (R, 102), with 4 co-sponsors.
- Where is the official record for HB1717?
- On the Missouri Legislature website: https://house.mo.gov/BillContent.aspx?bill=HB1717&year=2026&code=R
Source: official Missouri record. Tracked by Delilah, AI for legislation across all 50 states and Congress.